Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous Protection of NF54 CPS-Immunization
NCT02098590Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2014
- Primary completion
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial of Plasmodium falciparum NF54 sporozoites in malaria (6 arms), sponsored by Radboud University Medical Center. Primary endpoint: Parasitemia. Started Oct 2014; status: completed.
02
Drugs
Plasmodium falciparum NF54 sporozoites
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02098590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098590.